Ullrich先天性肌营养不良症合并多发骨折一例诊治研究及文献复习OA
Ullrich congenital muscular dystrophy with multiple fractures:a case study and literature review
目的 分析一例自幼起病,以反复轻微外力下骨折,伴有脊柱侧凸、肌力减退、斜颈为主要表现的罕见 Ullrich 先天性肌营养不良症(Ullrich congenital muscular dystrophy,UCMD)患儿的临床特点及致病基因突变,为该疾病的诊断、治疗研究提供参考.方法 收集患儿详细临床资料,包括病史、体格检查结果;测量骨转换生化指标、骨密度,通过骨骼 X 线评估骨骼病变情况;采用全外显子测序、聚合酶链式反应(polymerase chain reaction,PCR)及 Sanger 测序验证致病基因突变,结合生物信息学分析变异致病性;检索国内外相关文献,总结 UCMD 患者的基因谱及表型谱特点.结果 患儿为 10 岁女童,以反复轻微外力下骨折、关节韧带松弛、先天性髋关节脱位、肌张力减退、斜颈、严重脊柱畸形为主要表现.骨转换生化指标正常,骨密度明显减低,X 线片示缝间骨形成,脊柱严重后凸畸形.基因检测发现患儿携带 COL6A1 基因c.904G>A,p.Gly302Arg 杂合变异,明确诊断为 UCMD 合并骨质疏松症.予元素钙、骨化三醇联合地舒单抗治疗,治疗 28 个月后患儿骨吸收指标明显下降,骨密度明显增加.进而完成脊柱侧凸矫形手术,术后患儿身高增加 5.6 cm.复习文献,对 74 例 COL6A1 基因突变所致病例进行总结,发现疾病表型谱主要包括关节挛缩(89.2%)、关节韧带松弛(81.1%)、脊柱侧凸(58.1%)、肌张力减退(56.8%)、先天性髋关节脱位(36.5%)、运动功能发育迟缓(29.7%)、呼吸功能不全(21.6%)、先天性斜颈(9.5%).基因型-表型关联性分析发现,基因错义突变导致Ⅵ型胶原蛋白的甘氨酸改变与严重表型相关.结论 COL6A1 基因突变引起的罕见遗传性疾病 UCMD,以关节挛缩、脊柱侧凸、肌张力减退为主要表型,常合并骨质疏松及多发骨折.COL6A1 基因突变检测有助于揭示疾病分子机制,地舒单抗治疗对改善 UCMD 患者骨质疏松有益.
Objective To analyse the clinical characteristics and pathogenic gene mutations in a rare case of Ull-rich congenital muscular dystrophy(UCMD)presenting from infancy with recurrent fractures under minimal force,scoliosis,muscle weakness and torticollis and to provide a reference for the diagnosis and treatment of this disease.Methods De-tailed clinical data were collected,including medical history and physical examination findings.Bone turnover markers and bone mineral density were measured and skeletal X-rays were used to assess bone deformity.Pathogenic gene mutations were validated via whole-exome sequencing,polymerase chain reaction(PCR),Sanger sequencing and bioinformatics analysis of variant pathogenicity.A review of relevant literature was conducted to summarize the genetic and phenotypic characteristics of UCMD patients.Results The patient was a 10-year-old girl who presented with recurrent fractures under minor trauma,joint laxity,congenital hip dislocation,hypotonia,torticollis and severe spinal deformity.Although bone turnover markers were normal,bone mineral density was markedly low.Radiographs revealed inter-sutural ossification and severe kyphotic spi-nal deformity.Genetic testing identified a heterozygous variant in the COL6A1 gene(c.904G>A;p.Gly302Arg),confirming a diagnosis of UCMD with osteoporosis.Treatment with elemental calcium,calcitriol and denosumab for 28 months resulted in a significant reduction in bone resorption markers and an increase in bone mineral density.Subsequent scoliosis correction surgery resulted in an increase in the patient's height of 5.6 cm postoperatively.A literature review summarizing 74 cases of COL6A1 gene mutations revealed that the disease primarily presented with joint contractures(89.2%),joint laxity(81.1%),scoliosis(58.1%),hypotonia(56.8%),congenital hip dislocation(36.5%),delayed motor development(29.7%),respiratory insufficiency(21.6%)and congenital torticollis(9.5%).Genotype-phenotype correlation analysis revealed that missense mutations causing glycine substitution in type Ⅵ collagen was correlated with severe phenotypes.Conclusion As a rare hereditary disorder caused by COL6A1 gene mutations,UCMD primarily presents with joint contrac-tures,scoliosis and hypotonia,and is frequently accompanied by osteoporosis and multiple fractures.Detecting COL6A1 gene mutations helps to elucidate the molecular mechanisms of the disease,and denosumab could improve osteoporosis in UCMD patients.
张晓霞;孙磊;汪艳叶;孟令扬;王鸥;姜艳;邢小平;夏维波;李梅
100730 北京,中国医学科学院 北京协和医学院 北京协和医院内分泌科,国家卫生健康委员会内分泌重点实验室100730 北京,中国医学科学院 北京协和医学院 北京协和医院内分泌科,国家卫生健康委员会内分泌重点实验室100730 北京,中国医学科学院 北京协和医学院 北京协和医院内分泌科,国家卫生健康委员会内分泌重点实验室100730 北京,中国医学科学院 北京协和医学院 北京协和医院内分泌科,国家卫生健康委员会内分泌重点实验室100730 北京,中国医学科学院 北京协和医学院 北京协和医院内分泌科,国家卫生健康委员会内分泌重点实验室100730 北京,中国医学科学院 北京协和医学院 北京协和医院内分泌科,国家卫生健康委员会内分泌重点实验室100730 北京,中国医学科学院 北京协和医学院 北京协和医院内分泌科,国家卫生健康委员会内分泌重点实验室100730 北京,中国医学科学院 北京协和医学院 北京协和医院内分泌科,国家卫生健康委员会内分泌重点实验室100730 北京,中国医学科学院 北京协和医学院 北京协和医院内分泌科,国家卫生健康委员会内分泌重点实验室
医药卫生
COL6A1基因Ullrich先天性肌营养不良症骨折肌无力
COL6A1 geneUllrich congenital muscular dystrophybone fracturemuscular dystrophy
《中华骨质疏松和骨矿盐疾病杂志》 2026 (1)
34-42,9
国家重点研发计划(2021YFC2501700)"专科提升项目":中央高水平医院临床科研业务费资助(2022-PUMCH-B-014)
评论